Epigenetic markers of lithium response in bipolar disorder: optimization of a Methylation-Sensitive High-Resolution Melting assay (MS-HRM) and relevance in combination with clinical factors
Journal of Affective Disorders · 2026
DOI: 10.1016/j.jad.2025.120177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Céline Bourdon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Inserm, Optimisation Thérapeutique en Neuropsychopharmacologie, UMR-S 1144, F-75006 Paris, France. Electronic address: celine.…. Hauptthemen laut MEDLINE: Bipolar Disorder, DNA Methylation, Epigenesis, Genetic, Antimanic Agents. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre National de la Recherche Scientifique, Milken Institute, Université de Paris.
Abstract (Originalsprache)
Lithium (Li) is the most frequently recommended first-line treatment in bipolar disorder (BD). Nevertheless, response to Li is highly variable between individuals and no clinical or biological biomarkers have been consistently associated to long-term response. We previously identified 3 differentially methylated regions (DMRs) that discriminated good from non-responders to Li. In this study, we validated 4 additional DMRs using Methylation Specific High-Resolution Melting (MS-HRM), a PCR-based low-cost method with easy transferability from bench to bedside. In 61 individuals with BD-I, we investigated associations between these 7 DMRs and Li response, alone or combined with demographic and clinical variables. Using 7 DMRs and 6 demographic and clinical variables, 90 % of the BD-I individuals were correctly classified according to their response status (AUC = 0.95). In particular, combining DNA methylation markers with clinical predictors improved the identification of non-responders (83 % correctly classified). This epigenetic signature might be useful in clinical practice especially as it is imperative to avoid exposing individuals to Li if they have a very low likelihood of response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, Inserm, Optimisation Thérapeutique en Neuropsychopharmacologie, UMR-S 1144, F-75006 Paris, France. Electronic address: celine.bourdon@inserm.fr.
- Université Paris Cité, Inserm, Optimisation Thérapeutique en Neuropsychopharmacologie, UMR-S 1144, F-75006 Paris, France.
- Université Paris Cité, Inserm, Optimisation Thérapeutique en Neuropsychopharmacologie, UMR-S 1144, F-75006 Paris, France; Département de Psychiatrie et de Médecine Addictologique, Hôpitaux Lariboisière-Fernand Widal, GH…
- Institute of Neuroscience, Newcastle University, Newcastle upon Tyne NE4 5PL, UK.
Förderung
- Centre National de la Recherche Scientifique
- Milken Institute
- Université de Paris
- Institut National de la Santé et de la Recherche Médicale
- Inserm Transfert SA
Zitieren
APA
Bourdon, C., Courtin, C., Bellivier, F., Scott, J., Etain, B., & Marie-Claire, C. (2026). Epigenetic markers of lithium response in bipolar disorder: optimization of a Methylation-Sensitive High-Resolution Melting assay (MS-HRM) and relevance in combination with clinical factors. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.120177
Vancouver
Bourdon C, Courtin C, Bellivier F, Scott J, Etain B, Marie-Claire C. Epigenetic markers of lithium response in bipolar disorder: optimization of a Methylation-Sensitive High-Resolution Melting assay (MS-HRM) and relevance in combination with clinical factors. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2025.120177
BibTeX
@article{Bourdon2026,
author = {Bourdon, Céline and Courtin, Cindie and Bellivier, Frank and Scott, Jan and Etain, Bruno and Marie-Claire, Cynthia},
title = {Epigenetic markers of lithium response in bipolar disorder: optimization of a Methylation-Sensitive High-Resolution Melting assay (MS-HRM) and relevance in combination with clinical factors},
journal = {Journal of Affective Disorders},
year = {2026},
doi = {10.1016/j.jad.2025.120177}
}
EUVIMED